Peter Lipson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

If there's a story I neglected to mention last week that I should have, it's that Andrew Wakefield is being a bully again, trying to use legal intimidation to silence his critics, namely Forbes.com blogger Emily Willingham. Of course, Wakefield has done this so many times that the fact that he's done it once again is hardly newsworthy, but that never stopped me before, because it's important to document the pattern of legal harassment. The timing was bad.

Has they hype outpaced the evidence when it comes to cannabis? A new clinical trial fails to show any benefit of CBD oil in patients with advanced cancer.

It always irritates me when I discover a new antivaccine crank in my state; so you can imagine how irritated I become when I discover one right in my very city (OK, metropolitan area). When that happens, it becomes a bit more personal than my usual mission to refute antivaccine misinformation. So I was most alarmed when I discovered just such a beast because a former ScienceBlogs colleague now writing for Forbes, Dr.

Here we go again.

If there's one thing I've been consistent about, it's that, however ridiculous all the other woo I routinely discuss here is—homeopathy, reiki, reflexology, I'm talking to you and your friends—herbal medicine and supplements might have value because they might have a physiological effect that is beneficial in treating or preventing disease. Of course, if that's the case, it's because the herb or supplement contains chemicals that act as drugs.